Cargando…
A Narrative Review of a Pulmonary Aerosolized Formulation or a Nasal Drop Using Sera Containing Neutralizing Antibodies Collected from COVID-19–Recovered Patients as a Probable Therapy for COVID-19
Coronavirus disease 2019 (COVID-19) emerged as a new contagion during December 2019, since which time it has triggered a rampant spike in fatality rates worldwide due to insufficient medical treatments and a lack of counteragents and prompted the World Health Organization to declare COVID-19 a publi...
Autores principales: | Fatima, Nishat, Kaushik, Vichitra, Ayoub, Amjad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shiraz University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163704/ https://www.ncbi.nlm.nih.gov/pubmed/34083848 http://dx.doi.org/10.30476/ijms.2020.86417.1624 |
Ejemplares similares
-
Formulation and Evaluation of Almotriptan Malate Nasal Drops
por: Pradhan, V., et al.
Publicado: (2009) -
Sera proteomic features of active and recovered COVID-19 patients: potential diagnostic and prognostic biomarkers
por: Leng, Ling, et al.
Publicado: (2021) -
Neutralization Effect of Sera against Delta and Omicron in Patients Recovering from COVID-19 and Inactivated Vaccine Recipients
por: Zhu, Yajuan, et al.
Publicado: (2023) -
Chloroquine nasal drops in asymptomatic & mild COVID-19: An exploratory randomized clinical trial
por: Thakar, Alok, et al.
Publicado: (2021) -
Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naïve vaccinees
por: Yadav, Pragya D., et al.
Publicado: (2022)